SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following a Supreme Court ruling that struck down tariffs, challenging a core element of former President Trump's past economic policy and executive power. The community is widely debating the financial implications for consumers and businesses, including the prospect of significant tariff refunds, and the broader political repercussions.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending amid anticipation and delays surrounding a Supreme Court ruling on tariffs, a decision the community believes could significantly impact the company. However, many express frustration over NKE's inability to sustain gains, viewing its price action as a "value trap" despite ongoing strategic resets and efforts to reignite growth.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a dual financing announcement, including a $100 million public stock offering priced at $5.45 per share and a $100 million royalty funding deal with RTW Investments. While some in the community express concern over significant dilution, others view this as a strategic move that secures crucial runway for commercialization and validates the company's lead asset, CAN-2409, ahead of its BLA submission and ongoing trials.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The Supreme Court's ruling against Trump-era tariffs is driving conversation and a rally in SPY, as many perceive it as disinflationary and supportive of potential rate cuts, though bears remain skeptical, citing other concerning economic data and anticipating a market pullback.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending amidst reports of financing challenges for a major data center project and class-action lawsuits alleging misleading investors regarding capacity and delays. This has sparked a heated debate, with bears highlighting debt and an unsustainable model, while bulls dismiss the negative news as short-seller tactics ahead of anticipated strong earnings, often citing the company's substantial backlog and NVIDIA's investment.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a surge fueled by significant 800G/1.6T hyperscale customer orders and substantial investment in production for AI data centers, alongside rising analyst price targets. Community discussion highlights a potential short squeeze and its role in the booming optical sector, countered by concerns over its historical volatility and "pump and dump" tendencies.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon Athletica is trending as investors grapple with the delayed impact of a Supreme Court tariff decision and ongoing controversy surrounding its "Get Low" see-through leggings, compounded by founder Chip Wilson's public criticism of the board's product strategy and leadership void. The community is actively discussing the stock's muted response to positive holiday sales updates, fueling frustration over its recent underperformance and perceived manipulation despite its strong fundamentals and international growth.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG) is trending as its dedicated community celebrates a significant milestone, highlighting the project's unique passive Solana rewards mechanism for holders, alongside ongoing discussions about new features and liquidity pool enhancements.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending due to a substantial stock decline following mixed results from its NHS-Galleri trial, which missed its primary endpoint for reducing late-stage cancers but showed promising data in early detection, leading to sharp debate between those who see an overreaction and others predicting further declines.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to the early commercial success of its newly launched fibromyalgia drug, Tonmya, which is reportedly exceeding initial sales expectations and gaining broader insurance coverage. Despite persistent community frustration over historical share dilution and price performance, institutional investors are significantly increasing their positions, signaling confidence in the company's transition to a revenue-generating biotech with a promising non-opioid pain pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phoenix Life Sciences International is a global platform for the re-introduction of organic, plant-based pharmaceuticals and programs for creating healthcare solutions and reducing total cost of national healthcare programs Their business is to advance research and integrate programs and manufacturing of products that target and treat; diabetes, pain, cancers, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. Phoenix Life Sciences creating partnerships for integrating these programs for human health into communities worldwide as part of their Global Health Initiative. Working with developing nations on programs to improve affordable healthcare and creating industry. Phoenix Life Sciences uses organically produced plants, including cannabis, extracts the purest of active ingredients, and encapsulates them for maximum bioavailability and efficacy. Providing a patient-centric alternative to the low efficacy and the high side effects of conventional pharmaceuticals.

PLSI
Phoenix Life Sciences International Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest PLSI News

PLSIPhoenix Life Sciences International Ltd